Showing results (41-50 of 76) with videos related to
Sort By:
Pageof 8
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 28, 2004
Prospective randomized study of two laparotomy incisions for gastrectomy: midline incision versus transverse incisionTsuyoshi Inaba, Kota Okinaga, Ryoji Fukushima, et al.International Journal of Cancer|April 12, 2002
Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancerHisae Iinuma, Kazuo Maruyama, Kota Okinaga, et al.Journal of Hepato-Biliary-Pancreatic Sciences|December 19, 2018
Exosome-encapsulated microRNA-4525, microRNA-451a and microRNA-21 in portal vein blood is a high-sensitive liquid biomarker for the selection of high-risk pancreatic ductal adenocarcinoma patientsSachiyo Kawamura, Hisae Iinuma, Keita Wada, et al.Journal of Thoracic Disease|September 22, 2017
Does lung cancer surgery cause circulating tumor cells?-A multicenter, prospective studyNoriyuki Matsutani, Noriyoshi Sawabata, Masafumi Yamaguchi, et al.International Surgery|June 17, 2011
Invasive micropapillary carcinoma of the ascending colon--a report of a caseHajime Shibuya, Keiji Matsuda, Ryu Shimada, et al.Journal of Hepato-Biliary-Pancreatic Sciences|November 14, 2017
Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinomaKunihiko Takahasi, Hisae Iinuma, Keita Wada, et al.Oncology Reports|May 12, 2018
Exosome‑encapsulated microRNA‑23b as a minimally invasive liquid biomarker for the prediction of recurrence and prognosis of gastric cancer patients in each tumor stageYoshimasa Kumata, Hisae Iinuma, Yusuke Suzuki, et al.Oncology Letters|October 16, 2019
Plasma exosome-encapsulated microRNA-21 and microRNA-92a are promising biomarkers for the prediction of peritoneal recurrence in patients with gastric cancerNaruyoshi Soeda, Hisae Iinuma, Yusuke Suzuki, et al.International Journal of Colorectal Disease|September 4, 2019
Angiotensin I-converting enzyme inhibitors/angiotensin II receptor blockers may reduce tumor recurrence in left-sided and early colorectal cancersTsuyoshi Ozawa, Yojiro Hashiguchi, Takahiro Yagi, et al.Molecular and Clinical Oncology|September 10, 2019
Plasma exosomal microRNA-125b as a monitoring biomarker of resistance to mFOLFOX6-based chemotherapy in advanced and recurrent colorectal cancer patientsTakahiro Yagi, Hisae Iinuma, Tamuro Hayama, et al.Pageof 8